HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret E Brousseau Selected Research

Lipids

12/2010Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease.
9/2002New targets for medical treatment of lipid disorders.
7/2002Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret E Brousseau Research Topics

Disease

9Coronary Disease (Coronary Heart Disease)
12/2010 - 07/2002
3Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 08/2005
3Hypercholesterolemia
05/2005 - 01/2004
2Atherosclerosis
02/2003 - 04/2002
2Tangier Disease
02/2003 - 02/2003
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
03/2024
1Hyperlipidemias (Hyperlipidemia)
03/2024
1Myocardial Infarction
09/2007
1Dyslipidemias (Dyslipidemia)
09/2007
1Diabetes Mellitus
07/2006
1Insulin Resistance
07/2006
1Obesity
10/2004
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2004
1Chronic Renal Insufficiency
10/2004
1Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)
02/2003
1Abetalipoproteinemia (Bassen Kornzweig Syndrome)
12/2002
1Hypertriglyceridemia
09/2002

Drug/Important Bio-Agent (IBA)

6HDL CholesterolIBA
12/2010 - 07/2002
3oxidized low density lipoproteinIBA
03/2024 - 05/2003
3LipidsIBA
12/2010 - 07/2002
3Atorvastatin (Lipitor)FDA Link
05/2005 - 01/2004
3Lipoproteins (Lipoprotein)IBA
10/2004 - 12/2002
3CholesterolIBA
05/2003 - 04/2002
3ATP-Binding Cassette Transporters (ABC Transporters)IBA
02/2003 - 04/2002
2LDL CholesterolIBA
03/2024 - 05/2003
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2005 - 12/2004
2HDL LipoproteinsIBA
08/2005 - 04/2004
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
10/2004 - 04/2002
2Cholesterol Ester Transfer ProteinsIBA
07/2002 - 04/2002
1ALN-PCSIBA
03/2024
1AntibodiesIBA
01/2022
1Alanine (L-Alanine)FDA Link
09/2007
1Codon (Codons)IBA
09/2007
1Glucose (Dextrose)FDA LinkGeneric
09/2007
1Threonine (L-Threonine)FDA Link
09/2007
1Fatty Acid-Binding ProteinsIBA
09/2007
1Gemfibrozil (Lopid)FDA LinkGeneric
07/2006
1PPAR alphaIBA
07/2006
1torcetrapibIBA
05/2005
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2004
1DeuteriumIBA
10/2004
1Apolipoprotein B-100 (Apo B 100)IBA
10/2004
1Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2004
1ApolipoproteinsIBA
10/2004
1Leucine (L-Leucine)FDA Link
10/2004
1Cytochrome P-450 CYP3AIBA
01/2004
1Apolipoproteins E (ApoE)IBA
12/2002
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2002
1Lipase (Acid Lipase)FDA Link
04/2002
1EnzymesIBA
04/2002
1Scavenger Receptors (Scavenger Receptor)IBA
04/2002

Therapy/Procedure

5Therapeutics
08/2005 - 05/2003
1Secondary Prevention
09/2007
1Aftercare (After-Treatment)
01/2004